Popular Articles

NICE Recommends Use Of Cetuximab (Erbitux(R)) For UK Bowel Cancer Patients
The National Institute for Health and Clinical Excellence (NICE) has today published a Final Appraisal Determination (FAD) recommending the use of the drug cetuximab (Erbitux®) in combination with chemotherapy as a 1st-line treatment for patients with metastatic (advanced) colorectal cancer (mCRC) who have met specific additional criteria1* - presenting the possibility of potentially curative surgery.2 The treatment is recommended for patients in whom the cancer has spread only to the liver and who have "wild-type" (unmutated) KRASò€¡ tumours.1 Up to 65% of patients have wild-type KRAS tumours.3
drugs without prescription
Consumers Rate Medicare Higher Than Employer-Sponsored Insurance
Elderly Medicare beneficiaries are more satisfied with their health care, and experience fewer problems accessing and paying for care, than Americans with employer-sponsored insurance (ESI), according to a study by Commonwealth Fund researchers published May 12 on the Health Affairs Web site. If given the opportunity, many adults under age 65 would likely select a public health insurance option, say lead author Karen Davis, president of the Commonwealth Fund, and colleagues.
News of the day
Health Professionals Experience Difficulty Treating Patients With Dual Mental Health Diagnoses
The Washington Post tells the story of Danny Watt, who drowned in April 2008 after a lifelong struggle with mental health. Watt had a dual diagnosis: a serious mental illness along with abuse of drugs or alcohol.
Cardiovascular

As Patients Age, Future Physicians Develop End Of Life Skills

The American Medical Student Association (AMSA), the nation"s oldest and largest, independent association for physicians-in-training, is pleased to present the graduates of the AMSA Foundation-VITAS End of Life Education Fellowship Program. Five medical students have spent the past six weeks immersing themselves in end of life (EOL) care issues. The End of Life Education Fellowship Program is a six-week summer experience that combines an orientation to EOL care with weekly seminars and field placements at local hospices, nursing homes and inpatient units. VITAS, the nation"s leading provider of end-of-life care, has partnered with AMSA for the past five years. The program graduates are: - Dannie Chang, University of Michigan Medical School - Michelle Cormier, Florida State University College of Medicine - Brian Cousino, West Virginia School of Osteopathic Medicine - April Morrison, Lincoln Memorial University DeBusk College of Osteopathic Medicine - Khash Touloei, Western University of Osteopathic Medicine Students were part of an interdisciplinary hospice team consisting of doctors, nurses, social workers, chaplains, bereavement counselors and volunteers. They developed and practiced basic interviewing and communication skills essential to EOL care, while understanding the psychological, sociological, cultural and spiritual aspects of death and dying. While at their program sites, students developed EOL curricula to be implemented at their medical schools and to be shared with medical schools across the nation. "As the Baby Boomer generation ages, end of life skills are an essential part of medical education," says Dr. Lauren Hughes, MPH, AMSA national president. "AMSA urges all medical schools and residency programs to provide training to educate medical students and residents in issues of death and dying." For more information, please visit http://amsa.org/eol. American Medical Student Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):